S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

Clinical trial NCT00775645 · COMPLETED

Trial details

NCT number: NCT00775645
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Chemotherapeutic Agent Toxicity Fatigue Neuropathy Neurotoxicity

Start date: 2009-09-01
Primary completion: 2012-01-01
Enrollment: 437

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.